Earnings NYSE Nasdaq 100 U.S. Tech Politics AI Science SEC Business Wall Street Energy Bitcoin (BTC) Dow Jones Dividend NVIDIA (NVDA) Investing Markets Economy S&P 500 China World Donald Trump Fed Crude Oil Money Inflation Tesla (TSLA) Gold Software U.K. Entertainment Apple (AAPL) Health Amazon (AMZN) Retail Wealth Taxes Elon Musk Europe Real Estate Retirement Natural Gas 3M (MMM) Microsoft (MSFT) Security Meta Platforms (META) Current Canada Options Truist Financial Corp (TFC) Boeing (BA) Hedge Funds Jim Cramer Tax Insurance Google Sports Live Manufacturing Cars Pharmaceuticals Economics War Warren Buffett Ukraine Airlines Costco (COST) Mining Holidays Finance Japan York Silver Construction Goldman Sachs (GS) Interest Rates New York BlackRock (BLK) Walmart (WMT) Kamala Harris OpenAI ChatGPT Space REITs Mortgage Internet JPMorgan (JPM) Ethereum (ETH) Aerospace Enterprise Intel (INTC) Walt Disney (DIS) GBP USD Netflix (NFLX) India Texas IPOs Morgan Stanley (MS) AustraliaMore +
Stock Market News Stock Market News
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

4 days Incyte Pauses Enrollment in Chronic Spontaneous Urticaria StudyZacks

INCY stops enrollment in the phase II study of MRGPRX2 in CSU after making certain in vivo preclinical toxicology discoveries.

Incyte (INCY)

X       

2 days Goldman Sachs: Incyte Corporation (INCY) Is A Top Growth Investor StockInsider Monkey X       

3 days Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreZacks X       

5 days Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.Investor's Business Daily X       

5 days After-hours movers: Super Micro Computer, Bakkt Holdings, Incyte, and moreInvesting.com X       

6 days Is Incyt Corporation (INCY) the Best Immunotherapy Stock to Buy Now?Insider Monkey X       

3 weeks BMRN vs. INCY: Which Stock Is the Better Value Option?Zacks X       

3 weeks Incyte (NASDAQ:INCY) Announces Quarterly Earnings ResultsMarketBeat X       

3 weeks Earnings call: Incyte reports robust growth and pipeline progressInvesting.com X       

4 weeks Incyte (NASDAQ:INCY) Raised to “Buy” at Bank of AmericaMarketBeat X       

4 weeks Incyte Breaks Out To 17-Month High As Jakafi Demand SurgesInvestor's Business Daily X       

4 weeks INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product SalesZacks X       

4 weeks Here’s What Key Metrics Tell Us About Incyte (INCY) Q3 EarningsZacks X       

4 weeks Incyte Co. (NASDAQ:INCY) Shares Sold by Mediolanum International Funds LtdMarketBeat X       

4 weeks Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY)MarketBeat X       

1 month Incyte Gears Up to Report Q3 Earnings: Here’s What You Should KnowZacks X       

1 month Incyte (INCY) Scheduled to Post Quarterly Earnings on TuesdayMarketBeat X       

More news +
Home | Contact
  • X

© 2024 The Stock Market News